{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:24:51Z","timestamp":1792790691184,"version":"4.5.0"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:00:00Z","timestamp":1748304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:00:00Z","timestamp":1748304000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008363","name":"Kr\u00e6ftens Bek\u00e6mpelse","doi-asserted-by":"publisher","award":["R167-A10877"],"award-info":[{"award-number":["R167-A10877"]}],"id":[{"id":"10.13039\/100008363","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008363","name":"Kr\u00e6ftens Bek\u00e6mpelse","doi-asserted-by":"publisher","award":["R223-A13071"],"award-info":[{"award-number":["R223-A13071"]}],"id":[{"id":"10.13039\/100008363","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNF17CC0027852"],"award-info":[{"award-number":["NNF17CC0027852"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000650","name":"Institute of Cancer Research, Royal Cancer Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000650","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Kirsten and Freddy Johansen\u2019s Research Prize Greater Copenhagen Health Science Partners","id":[{"id":"https:\/\/ror.org\/02ebqtm87","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C57799\/A27964"],"award-info":[{"award-number":["C57799\/A27964"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The lack of curative therapies for acute myeloid leukaemia (AML) remains an ongoing challenge despite recent advances in the understanding of the molecular basis of the disease. Here we identify the WNK1-OXSR1\/STK39 pathway as a previously uncharacterised dependency in AML. We show that genetic depletion and pharmacological inhibition of WNK1 or its downstream phosphorylation targets OXSR1 and STK39 strongly reduce cell proliferation and induce apoptosis in leukaemia cells in vitro and in vivo. Furthermore, we show that the WNK1-OXSR1\/STK39 pathway controls mTORC1 signalling via regulating amino acid uptake through a mechanism involving the phosphorylation of amino acid transporters, such as SLC38A2. Our findings underscore an important role of the WNK1-OXSR1\/STK39 pathway in regulating amino acid uptake and driving AML progression.<\/jats:p>","DOI":"10.1038\/s41467-025-59969-8","type":"journal-article","created":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T13:06:11Z","timestamp":1748351171000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["WNK1 signalling regulates amino acid transport and mTORC1 activity to sustain acute myeloid leukaemia growth"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0548-5150","authenticated-orcid":false,"given":"Shunlei","family":"Duan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Agger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan-Erik","family":"Messling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koutarou","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuerui","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2987-6538","authenticated-orcid":false,"given":"Isabel","family":"Pe\u00f1a-R\u00f8mer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Shliaha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4459-7534","authenticated-orcid":false,"given":"Helene","family":"Damhofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1186-7163","authenticated-orcid":false,"given":"Max","family":"Douglas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3904-2158","authenticated-orcid":false,"given":"Manas","family":"Kohli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akos","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3112-8694","authenticated-orcid":false,"given":"Yasmin","family":"Asad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6989-4394","authenticated-orcid":false,"given":"Aaron","family":"Van Dyke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3370-5501","authenticated-orcid":false,"given":"Robert","family":"K\u00f6chl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2439-0798","authenticated-orcid":false,"given":"Victor L. J.","family":"Tybulewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald C.","family":"Hendrickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0957-6279","authenticated-orcid":false,"given":"Florence I.","family":"Raynaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7254-2253","authenticated-orcid":false,"given":"Paolo","family":"Gallipoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0529-8614","authenticated-orcid":false,"given":"George","family":"Poulogiannis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1975-6097","authenticated-orcid":false,"given":"Kristian","family":"Helin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,27]]},"reference":[{"key":"59969_CR1","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1056\/NEJMra1406184","volume":"373","author":"H Dohner","year":"2015","unstructured":"Dohner, H., Weisdorf, D. J. & Bloomfield, C. D. Acute myeloid leukemia. N. Engl. J. Med. 373, 1136\u20131152 (2015).","journal-title":"N. Engl. J. Med."},{"key":"59969_CR2","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","volume":"129","author":"H Dohner","year":"2017","unstructured":"Dohner, H. et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood 129, 424\u2013447 (2017).","journal-title":"Blood"},{"key":"59969_CR3","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","volume":"374","author":"E Papaemmanuil","year":"2016","unstructured":"Papaemmanuil, E. et al. Genomic classification and prognosis in acute myeloid leukemia. N. Engl. J. Med. 374, 2209\u20132221 (2016).","journal-title":"N. Engl. J. Med."},{"key":"59969_CR4","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","volume":"368","author":"TJ Ley","year":"2013","unstructured":"Ley, T. J. et al. Genomic and epigenomic landscapes of adult De Novo acute myeloid leukemia. N. Engl. J. Med. 368, 2059\u20132074 (2013).","journal-title":"N. Engl. J. Med."},{"key":"59969_CR5","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1158\/2159-8290.CD-19-1011","volume":"10","author":"NJ Short","year":"2020","unstructured":"Short, N. J. et al. Advances in the treatment of acute myeloid leukemia: new drugs and new challenges. Cancer Discov. 10, 506\u2013525 (2020).","journal-title":"Cancer Discov."},{"key":"59969_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-021-00425-3","volume":"11","author":"H Kantarjian","year":"2021","unstructured":"Kantarjian, H. et al. Acute myeloid leukemia: current progress and future directions. Blood Cancer J. 11, 41 (2021).","journal-title":"Blood Cancer J."},{"key":"59969_CR7","doi-asserted-by":"publisher","first-page":"16795","DOI":"10.1074\/jbc.275.22.16795","volume":"275","author":"B Xu","year":"2000","unstructured":"Xu, B. et al. WNK1, a novel mammalian serine\/threonine protein kinase lacking the catalytic lysine in subdomain II. J. Biol. Chem. 275, 16795\u201316801 (2000).","journal-title":"J. Biol. Chem."},{"key":"59969_CR8","doi-asserted-by":"publisher","first-page":"5562","DOI":"10.1038\/sj.onc.1204726","volume":"20","author":"F Verissimo","year":"2001","unstructured":"Verissimo, F. & Jordan, P. WNK kinases, a novel protein kinase subfamily in multi-cellular organisms. Oncogene 20, 5562\u20135569 (2001).","journal-title":"Oncogene"},{"key":"59969_CR9","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1152\/physrev.00017.2010","volume":"91","author":"JA McCormick","year":"2011","unstructured":"McCormick, J. A. & Ellison, D. H. The WNKs: a typical protein kinases with pleiotropic actions. Physiol. Rev. 91, 177\u2013219 (2011).","journal-title":"Physiol. Rev."},{"key":"59969_CR10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1042\/BJ20051180","volume":"391","author":"AC Vitari","year":"2005","unstructured":"Vitari, A. C., Deak, M., Morrice, N. A. & Alessi, D. R. The WNK1 and WNK4 protein kinases that are mutated in Gordon\u2019s hypertension syndrome phosphorylate and activate SPAK and OSR1 protein kinases. Biochem. J. 391, 17\u201324 (2005).","journal-title":"Biochem. J."},{"key":"59969_CR11","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1172\/JCI17443","volume":"111","author":"CL Yang","year":"2003","unstructured":"Yang, C. L., Angell, J., Mitchell, R. & Ellison, D. H. WNK kinases regulate thiazide-sensitive Na-Cl cotransport.\u00a0J. Clin. Invest. 111, 1039\u20131045 (2003).","journal-title":"J. Clin. Invest."},{"key":"59969_CR12","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1073\/pnas.242735399","volume":"100","author":"FH Wilson","year":"2003","unstructured":"Wilson, F. H. et al. Molecular pathogenesis of inherited hypertension with hyperkalemia: the Na-Cl cotransporter is inhibited by wild-type but not mutant WNK4. Proc. Natl. Acad. Sci.100, 680\u2013684 (2003).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"59969_CR13","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1242\/jcs.025312","volume":"121","author":"C Richardson","year":"2008","unstructured":"Richardson, C. et al. Activation of the thiazide-sensitive Na+-Cl- cotransporter by the WNK-regulated kinases SPAK and OSR1. J. Cell Sci. 121, 675\u2013684 (2008).","journal-title":"J. Cell Sci."},{"key":"59969_CR14","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1042\/BJ20060220","volume":"397","author":"AC Vitari","year":"2006","unstructured":"Vitari, A. C. et al. Functional interactions of the SPAK\/OSR1 kinases with their upstream activator WNK1 and downstream substrate NKCC1. Biochem. J. 397, 223\u2013231 (2006).","journal-title":"Biochem. J."},{"key":"59969_CR15","doi-asserted-by":"crossref","unstructured":"Jung, J. U., Taylor, C.A.t. & Cobb, M. H. Crank up the volume: osmotic stress induces WNK1 phase separation. Cell Res. 33, 265\u2013266 (2022).","DOI":"10.1038\/s41422-022-00763-2"},{"key":"59969_CR16","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1146\/annurev-physiol-021115-105431","volume":"78","author":"J Hadchouel","year":"2016","unstructured":"Hadchouel, J., Ellison, D. H. & Gamba, G. Regulation of renal electrolyte transport by WNK and SPAK-OSR1 kinases. Annu Rev. Physiol. 78, 367\u2013389 (2016).","journal-title":"Annu Rev. Physiol."},{"key":"59969_CR17","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.cmet.2017.01.007","volume":"25","author":"M Shekarabi","year":"2017","unstructured":"Shekarabi, M. et al. WNK kinase signaling in ion homeostasis and human disease. Cell Metab. 25, 285\u2013299 (2017).","journal-title":"Cell Metab."},{"key":"59969_CR18","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.cell.2009.05.031","volume":"138","author":"J Rinehart","year":"2009","unstructured":"Rinehart, J. et al. Sites of regulated phosphorylation that control K-Cl cotransporter activity. Cell 138, 525\u2013536 (2009).","journal-title":"Cell"},{"key":"59969_CR19","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1126\/science.1062844","volume":"293","author":"FH Wilson","year":"2001","unstructured":"Wilson, F. H. et al. Human hypertension caused by mutations in WNK kinases. Science 293, 1107\u20131112 (2001).","journal-title":"Science"},{"key":"59969_CR20","doi-asserted-by":"publisher","first-page":"7099","DOI":"10.1021\/acs.jmedchem.7b00708","volume":"60","author":"K Yamada","year":"2017","unstructured":"Yamada, K. et al. Optimization of allosteric with-no-lysine (WNK) kinase inhibitors and efficacy in rodent hypertension models. J. Med. Chem. 60, 7099\u20137107 (2017).","journal-title":"J. Med. Chem."},{"key":"59969_CR21","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1038\/nchembio.2168","volume":"12","author":"K Yamada","year":"2016","unstructured":"Yamada, K. et al. Small-molecule WNK inhibition regulates cardiovascular and renal function. Nat. Chem. Biol. 12, 896 (2016).","journal-title":"Nat. Chem. Biol."},{"key":"59969_CR22","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1146\/annurev.physiol.70.113006.100651","volume":"70","author":"KT Kahle","year":"2008","unstructured":"Kahle, K. T., Ring, A. M. & Lifton, R. P. Molecular physiology of the WNK kinases. Annu. Rev. Physiol. 70, 329\u2013355 (2008).","journal-title":"Annu. Rev. Physiol."},{"key":"59969_CR23","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/bs.ctm.2018.08.002","volume":"81","author":"P de Los Heros","year":"2018","unstructured":"de Los Heros, P., Pacheco-Alvarez, D. & Gamba, G. Role of WNK kinases in the modulation of cell volume. Curr. Top. Membr. 81, 207\u2013235 (2018).","journal-title":"Curr. Top. Membr."},{"key":"59969_CR24","doi-asserted-by":"publisher","first-page":"4488","DOI":"10.1016\/j.cell.2022.09.042","volume":"185","author":"CR Boyd-Shiwarski","year":"2022","unstructured":"Boyd-Shiwarski, C. R. et al. WNK kinases sense molecular crowding and rescue cell volume via phase separation. Cell 185, 4488\u20134506 (2022).","journal-title":"Cell"},{"key":"59969_CR25","doi-asserted-by":"publisher","first-page":"14342","DOI":"10.1073\/pnas.1617649113","volume":"113","author":"SG Kankanamalage","year":"2016","unstructured":"Kankanamalage, S. G. et al. Multistep regulation of autophagy by WNK1. Proc. Natl. Acad. Sci.113, 14342\u201314347 (2016).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"59969_CR26","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1080\/15548627.2017.1286431","volume":"13","author":"SG Kankanamalage","year":"2017","unstructured":"Kankanamalage, S. G. et al. WNK1 is an unexpected autophagy inhibitor. Autophagy 13, 969\u2013970 (2017).","journal-title":"Autophagy"},{"key":"59969_CR27","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1073\/pnas.1018567108","volume":"108","author":"SW Tu","year":"2011","unstructured":"Tu, S. W., Bugde, A., Luby-Phelps, K. & Cobb, M. H. WNK1 is required for mitosis and abscission. Proc. Natl. Acad. Sci.108, 1385\u20131390 (2011).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"59969_CR28","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1038\/s41556-019-0431-1","volume":"21","author":"JSA Perry","year":"2019","unstructured":"Perry, J. S. A. et al. Interpreting an apoptotic corpse as anti-inflammatory involves a chloride sensing pathway. Nat. Cell Biol. 21, 1532\u20131543 (2019).","journal-title":"Nat. Cell Biol."},{"key":"59969_CR29","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1016\/j.molcel.2021.04.013","volume":"81","author":"T Pleiner","year":"2021","unstructured":"Pleiner, T. et al. WNK1 is an assembly factor for the human ER membrane protein complex. Mol. Cell 81, 2693\u20132704 (2021).","journal-title":"Mol. Cell"},{"key":"59969_CR30","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1038\/ni.3495","volume":"17","author":"R K\u00f6chl","year":"2016","unstructured":"K\u00f6chl, R. et al. WNK1 kinase balances T cell adhesion versus migration in vivo. Nat. Immunol. 17, 1075\u20131083 (2016).","journal-title":"Nat. Immunol."},{"key":"59969_CR31","doi-asserted-by":"crossref","unstructured":"Hayward, D. A. et al. B cell-intrinsic requirement for WNK1 kinase in antibody responses in mice. J. Exp. Med. 220, e20211827(2023).","DOI":"10.1084\/jem.20211827"},{"key":"59969_CR32","unstructured":"Leonard, L. D. B. et al. T cell migration requires ion and water influx to regulate actin polymerization. bioRxiv, 2022.2003.2016.484584 (2022)."},{"key":"59969_CR33","unstructured":"Joshua Biggs, O. M. et al. Water influx is required for CD4<sup>+<\/sup> T cell activation and T cell-dependent antibody responses. bioRxiv, 2022.2003.2016.484637 (2022)."},{"key":"59969_CR34","doi-asserted-by":"crossref","unstructured":"Kochl, R. et al. Critical role of WNK1 in MYC-dependent early mouse thymocyte development. Elife 9, e56934 (2020).","DOI":"10.7554\/eLife.56934"},{"key":"59969_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24784-4","volume":"12","author":"L Mayes-Hopfinger","year":"2021","unstructured":"Mayes-Hopfinger, L. et al. Chloride sensing by WNK1 regulates NLRP3 inflammasome activation and pyroptosis. Nat. Commun. 12, 4546 (2021).","journal-title":"Nat. Commun."},{"key":"59969_CR36","doi-asserted-by":"crossref","unstructured":"Xiu, M. X., Li, L., Li, Y. D. & Gao, Y. An update regarding the role of WNK kinases in cancer. Cell Death Dis. 13, 795 (2022).","DOI":"10.1038\/s41419-022-05249-y"},{"key":"59969_CR37","doi-asserted-by":"publisher","first-page":"11707","DOI":"10.1073\/pnas.0306880101","volume":"101","author":"S Caenepeel","year":"2004","unstructured":"Caenepeel, S., Charydczak, G., Sudarsanam, S., Hunter, T. & Manning, G. The mouse kinome: discovery and comparative genomics of all mouse protein kinases. Proc. Natl. Acad. Sci.101, 11707\u201311712 (2004).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"59969_CR38","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1101\/gad.280495.116","volume":"30","author":"K Agger","year":"2016","unstructured":"Agger, K. et al. Jmjd2\/Kdm4 demethylases are required for expression of Il3ra and survival of acute myeloid leukemia cells. Genes Dev. 30, 1278\u20131288 (2016).","journal-title":"Genes Dev."},{"key":"59969_CR39","doi-asserted-by":"publisher","first-page":"2955","DOI":"10.1172\/JCI43354","volume":"122","author":"HS Radomska","year":"2012","unstructured":"Radomska, H. S. et al. Targeting CDK1 promotes FLT3-activated acute myeloid leukemia differentiation through C\/EBP alpha. J. Clin. Investig. 122, 2955\u20132966 (2012).","journal-title":"J. Clin. Investig."},{"key":"59969_CR40","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1182\/blood-2018-08-870089","volume":"133","author":"EM Beauchamp","year":"2019","unstructured":"Beauchamp, E. M. et al. Identification and targeting of novel CDK9 complexes in acute myeloid leukemia. Blood 133, 1171\u20131185 (2019).","journal-title":"Blood"},{"key":"59969_CR41","doi-asserted-by":"crossref","unstructured":"Morgado-Palacin, I. et al. Targeting the kinase activities of ATR and ATM exhibits antitumoral activity in mouse models of MLL-rearranged AML. Sci. Signal 9, ra91 (2016).","DOI":"10.1126\/scisignal.aad8243"},{"key":"59969_CR42","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.1182\/blood-2013-05-505735","volume":"123","author":"AM Cook","year":"2014","unstructured":"Cook, A. M. et al. Role of altered growth factor receptor-mediated JAK2 signaling in growth and maintenance of human acute myeloid leukemia stem cells. Blood 123, 2826\u20132837 (2014).","journal-title":"Blood"},{"key":"59969_CR43","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1182\/blood.2021012629","volume":"139","author":"JE Messling","year":"2022","unstructured":"Messling, J. E. et al. Targeting RIOK2 ATPase activity leads to decreased protein synthesis and cell death in acute myeloid leukemia. Blood 139, 245\u2013255 (2022).","journal-title":"Blood"},{"key":"59969_CR44","doi-asserted-by":"crossref","unstructured":"Shimada, K., Bachman, J. A., Muhlich, J. L. & Mitchison, T. J. shinyDepMap, a tool to identify targetable cancer genes and their functional connections from cancer dependency map data. Elife 10, e57116 (2021).","DOI":"10.7554\/eLife.57116"},{"key":"59969_CR45","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1038\/ng.3984","volume":"49","author":"RM Meyers","year":"2017","unstructured":"Meyers, R. M. et al. Computational correction of copy number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells. Nat. Genet. 49, 1779 (2017).","journal-title":"Nat. Genet."},{"key":"59969_CR46","doi-asserted-by":"crossref","unstructured":"Parrish, P. C. R. et al. Discovery of synthetic lethal and tumor suppressor paralog pairs in the human genome. Cell Rep. 36, 109597 (2021).","DOI":"10.1016\/j.celrep.2021.109597"},{"key":"59969_CR47","doi-asserted-by":"publisher","first-page":"42685","DOI":"10.1074\/jbc.M510042200","volume":"280","author":"T Moriguchi","year":"2005","unstructured":"Moriguchi, T. et al. WNK1 regulates phosphorylation of cation-chloride-coupled cotransporters via the STE20-related kinases, SPAK and OSR1. J. Biol. Chem. 280, 42685\u201342693 (2005).","journal-title":"J. Biol. Chem."},{"key":"59969_CR48","doi-asserted-by":"crossref","unstructured":"Alessi, D. R. et al. The WNK-SPAK\/OSR1 pathway: master regulator of cation-chloride cotransporters. Sci. Signal 7, re3 (2014).","DOI":"10.1126\/scisignal.2005365"},{"key":"59969_CR49","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1038\/s41375-024-02390-9","volume":"38","author":"V Dembitz","year":"2024","unstructured":"Dembitz, V. et al. Stearoyl-CoA desaturase inhibition is toxic to acute myeloid leukemia displaying high levels of the de novo fatty acid biosynthesis and desaturation. Leukemia 38, 2332\u20132343 (2024).","journal-title":"Leukemia"},{"key":"59969_CR50","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/s41580-020-0219-y","volume":"21","author":"GY Liu","year":"2020","unstructured":"Liu, G. Y. & Sabatini, D. M. mTOR at the nexus of nutrition, growth, ageing and disease. Nat. Rev. Mol. Cell Bio. 21, 246\u2013246 (2020).","journal-title":"Nat. Rev. Mol. Cell Bio."},{"key":"59969_CR51","doi-asserted-by":"publisher","first-page":"8077","DOI":"10.1093\/nar\/gkv748","volume":"43","author":"RM Lahr","year":"2015","unstructured":"Lahr, R. M. et al. The La-related protein 1-specific domain repurposes HEAT-like repeats to directly bind a 5 \u2018 TOP sequence. Nucleic Acids Res. 43, 8077\u20138088 (2015).","journal-title":"Nucleic Acids Res."},{"key":"59969_CR52","doi-asserted-by":"publisher","first-page":"736","DOI":"10.15252\/embj.201694966","volume":"36","author":"M Barilari","year":"2017","unstructured":"Barilari, M. et al. ZRF1 is a novel S6 kinase substrate that drives the senescence programme. Embo J. 36, 736\u2013750 (2017).","journal-title":"Embo J."},{"key":"59969_CR53","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s41556-018-0205-1","volume":"21","author":"J Kim","year":"2019","unstructured":"Kim, J. & Guan, K. L. mTOR as a central hub of nutrient signalling and cell growth. Nat. Cell Biol. 21, 63\u201371 (2019).","journal-title":"Nat. Cell Biol."},{"key":"59969_CR54","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1182\/blood-2011-11-393934","volume":"120","author":"ZH Zeng","year":"2012","unstructured":"Zeng, Z. H. et al. Targeting of mTORC1\/2 by the mTOR kinase inhibitor PP242 induces apoptosis in AML cells under conditions mimicking the bone marrow microenvironment. Blood 120, 2679\u20132689 (2012).","journal-title":"Blood"},{"key":"59969_CR55","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nm.2091","volume":"16","author":"MR Janes","year":"2010","unstructured":"Janes, M. R. et al. Effective and selective targeting of leukemia cells using a TORC1\/2 kinase inhibitor. Nat. Med. 16, 205\u2013213 (2010).","journal-title":"Nat. Med."},{"key":"59969_CR56","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1182\/blood-2004-06-2494","volume":"105","author":"C Recher","year":"2005","unstructured":"Recher, C. et al. Antileukemic activity of rapamycin in acute myeloid leukemia. Blood 105, 2527\u20132534 (2005).","journal-title":"Blood"},{"key":"59969_CR57","doi-asserted-by":"publisher","first-page":"17414","DOI":"10.1073\/pnas.0809136105","volume":"105","author":"AY Choo","year":"2008","unstructured":"Choo, A. Y., Yoon, S. O., Kim, S. G., Roux, P. P. & Blenis, J. Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation. Proc. Natl. Acad. Sci.105, 17414\u201317419 (2008).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"59969_CR58","doi-asserted-by":"publisher","first-page":"8023","DOI":"10.1074\/jbc.M900301200","volume":"284","author":"CC Thoreen","year":"2009","unstructured":"Thoreen, C. C. et al. An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1. J. Biol. Chem. 284, 8023\u20138032 (2009).","journal-title":"J. Biol. Chem."},{"key":"59969_CR59","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nrm2672","volume":"10","author":"XJM Ma","year":"2009","unstructured":"Ma, X. J. M. & Blenis, J. Molecular mechanisms of mTOR-mediated translational control. Nat. Rev. Mol. Cell Bio. 10, 307\u2013318 (2009).","journal-title":"Nat. Rev. Mol. Cell Bio."},{"key":"59969_CR60","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/ncb1547","volume":"9","author":"E Vander Haar","year":"2007","unstructured":"Vander Haar, E., Lee, S., Bandhakavi, S., Griffin, T. J. & Kim, D. H. Insulin signalling to mTOR mediated by the Akt\/PKB substrate PRAS40. Nat. Cell Biol. 9, 316\u2013323 (2007).","journal-title":"Nat. Cell Biol."},{"key":"59969_CR61","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.molcel.2007.03.003","volume":"25","author":"Y Sancak","year":"2007","unstructured":"Sancak, Y. et al. PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase. Mol. Cell 25, 903\u2013915 (2007).","journal-title":"Mol. Cell"},{"key":"59969_CR62","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.molcel.2008.03.003","volume":"30","author":"DM Gwinn","year":"2008","unstructured":"Gwinn, D. M. et al. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol. Cell 30, 214\u2013226 (2008).","journal-title":"Mol. Cell"},{"key":"59969_CR63","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/S0092-8674(03)00929-2","volume":"115","author":"K Inoki","year":"2003","unstructured":"Inoki, K., Zhu, T. Q. & Guan, K. L. TSC2 mediates cellular energy response to control cell growth and survival. Cell 115, 577\u2013590 (2003).","journal-title":"Cell"},{"key":"59969_CR64","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1126\/science.1232044","volume":"340","author":"L Bar-Peled","year":"2013","unstructured":"Bar-Peled, L. et al. A tumor suppressor complex with GAP activity for the rag GTPases that signal amino acid sufficiency to mTORC1. Science 340, 1100\u20131106 (2013).","journal-title":"Science"},{"key":"59969_CR65","doi-asserted-by":"publisher","first-page":"27879","DOI":"10.1074\/jbc.271.44.27879","volume":"271","author":"SA Hawley","year":"1996","unstructured":"Hawley, S. A. et al. Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase. J. Biol. Chem. 271, 27879\u201327887 (1996).","journal-title":"J. Biol. Chem."},{"key":"59969_CR66","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.cell.2012.12.016","volume":"152","author":"J Kim","year":"2013","unstructured":"Kim, J. et al. Differential regulation of distinct Vps34 complexes by AMPK in nutrient stress and autophagy. Cell 152, 290\u2013303 (2013).","journal-title":"Cell"},{"key":"59969_CR67","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.molcel.2020.09.006","volume":"80","author":"WM Wang","year":"2020","unstructured":"Wang, W. M. & Zou, W. P. Amino acids and their transporters in T cell immunity and cancer therapy. Mol. Cell 80, 384\u2013395 (2020).","journal-title":"Mol. Cell"},{"key":"59969_CR68","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.cell.2008.11.044","volume":"136","author":"P Nicklin","year":"2009","unstructured":"Nicklin, P. et al. Bidirectional transport of amino acids regulates mTOR and autophagy. Cell 136, 521\u2013534 (2009).","journal-title":"Cell"},{"key":"59969_CR69","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.cell.2021.02.021","volume":"184","author":"HL Huang","year":"2021","unstructured":"Huang, H. L. et al. In vivo CRISPR screening reveals nutrient signaling processes underpinning CD8(+) T cell fate decisions. Cell 184, 1245\u20131261 (2021).","journal-title":"Cell"},{"key":"59969_CR70","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.ccell.2015.02.006","volume":"27","author":"YJ Jeon","year":"2015","unstructured":"Jeon, Y. J. et al. Regulation of glutamine carrier proteins by RNF5 determines breast cancer response to ER stress-inducing chemotherapies. Cancer Cell 27, 354\u2013369 (2015).","journal-title":"Cancer Cell"},{"key":"59969_CR71","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/s41416-020-01113-y","volume":"124","author":"M Morotti","year":"2021","unstructured":"Morotti, M. et al. Increased expression of glutamine transporter SNAT2\/SLC38A2 promotes glutamine dependence and oxidative stress resistance, and is associated with worse prognosis in triple-negative breast cancer. Brit J. Cancer 124, 494\u2013505 (2021).","journal-title":"Brit J. Cancer"},{"key":"59969_CR72","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00424-013-1393-y","volume":"466","author":"S Bror","year":"2014","unstructured":"Bror, S. The SLC38 family of sodium-amino acid co-transporters. Pflug. Arch.-Eur. J. Physiol. 466, 155\u2013172 (2014).","journal-title":"Pflug. Arch.-Eur. J. Physiol."},{"key":"59969_CR73","doi-asserted-by":"publisher","first-page":"50812","DOI":"10.1074\/jbc.M208108200","volume":"277","author":"K Piechotta","year":"2002","unstructured":"Piechotta, K., Lu, J. M. & Delpire, E. Cation chloride cotransporters interact with the stress-related kinases Ste20-kelated proline-alanine-rich kinase (SPAK) and oxidative stress response 1 (OSR1). J. Biol. Chem. 277, 50812\u201350819 (2002).","journal-title":"J. Biol. Chem."},{"key":"59969_CR74","doi-asserted-by":"publisher","first-page":"4012","DOI":"10.1074\/jbc.RA118.006378","volume":"294","author":"A Broer","year":"2019","unstructured":"Broer, A. et al. Ablation of the ASCT2 (SLC1A5) gene encoding a neutral amino acid transporter reveals transporter plasticity and redundancy in cancer cells. J. Biol. Chem. 294, 4012\u20134026 (2019).","journal-title":"J. Biol. Chem."},{"key":"59969_CR75","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01827-6","volume":"22","author":"A Glaviano","year":"2023","unstructured":"Glaviano, A. et al. PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer. Mol. Cancer 22, 138 (2023).","journal-title":"Mol. Cancer"},{"key":"59969_CR76","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/s41573-021-00209-1","volume":"20","author":"B Vanhaesebroeck","year":"2021","unstructured":"Vanhaesebroeck, B., Perry, M. W. D., Brown, J. R., Andre, F. & Okkenhaug, K. PI3K inhibitors are finally coming of age. Nat. Rev. Drug Discov. 20, 741\u2013769 (2021).","journal-title":"Nat. Rev. Drug Discov."},{"key":"59969_CR77","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/s41568-018-0074-8","volume":"18","author":"D Mossmann","year":"2018","unstructured":"Mossmann, D., Park, S. & Hall, M. N. mTOR signalling and cellular metabolism are mutual determinants in cancer. Nat. Rev. Cancer 18, 744\u2013757 (2018).","journal-title":"Nat. Rev. Cancer"},{"key":"59969_CR78","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41573-021-00339-6","volume":"21","author":"ZE Stine","year":"2022","unstructured":"Stine, Z. E., Schug, Z. T., Salvino, J. M. & Dang, C. V. Targeting cancer metabolism in the era of precision oncology. Nat. Rev. Drug Discov. 21, 141\u2013162 (2022).","journal-title":"Nat. Rev. Drug Discov."},{"key":"59969_CR79","unstructured":"Najumudeen, A. K. et al. The amino acid transporter SLC7A5 is required for efficient growth of KRAS-mutant colorectal cancer. Nat. Genet. 53, 16\u201326 (2021)."},{"key":"59969_CR80","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1158\/2159-8290.CD-19-0959","volume":"10","author":"SJ Parker","year":"2020","unstructured":"Parker, S. J. et al. Selective alanine transporter utilization creates a targetable metabolic niche in pancreatic cancer. Cancer Discov. 10, 1018\u20131037 (2020).","journal-title":"Cancer Discov."},{"key":"59969_CR81","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.tibs.2018.05.003","volume":"43","author":"P Kandasamy","year":"2018","unstructured":"Kandasamy, P., Gyimesi, G., Kanai, Y. & Hediger, M. A. Amino acid transporters revisited: new views in health and disease. Trends Biochem. Sci. 43, 752\u2013789 (2018).","journal-title":"Trends Biochem. Sci."},{"key":"59969_CR82","doi-asserted-by":"crossref","unstructured":"Broer, S. Amino acid transporters as targets for cancer therapy: why, where, when, and how. Int. J. Mol. Sci. 21, 6156 (2020).","DOI":"10.3390\/ijms21176156"},{"key":"59969_CR83","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.1016\/j.celrep.2017.11.027","volume":"21","author":"D Krokowski","year":"2017","unstructured":"Krokowski, D. et al. GADD34 function in protein trafficking promotes adaptation to hyperosmotic stress in human corneal cells. Cell Rep. 21, 2895\u20132910 (2017).","journal-title":"Cell Rep."},{"key":"59969_CR84","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1182\/blood-2017-12-820035","volume":"131","author":"P Gallipoli","year":"2018","unstructured":"Gallipoli, P. et al. Glutaminolysis is a metabolic dependency in FLT3 (ITD) acute myeloid leukemia unmasked by FLT3 tyrosine kinase inhibition. Blood 131, 1639\u20131653 (2018).","journal-title":"Blood"},{"key":"59969_CR85","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1182\/blood-2015-01-621870","volume":"126","author":"N Jacque","year":"2015","unstructured":"Jacque, N. et al. Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition. Blood 126, 1346\u20131356 (2015).","journal-title":"Blood"},{"key":"59969_CR86","doi-asserted-by":"publisher","first-page":"3521","DOI":"10.1182\/blood-2013-03-493163","volume":"122","author":"L Willems","year":"2013","unstructured":"Willems, L. et al. Inhibiting glutamine uptake represents an attractive new strategy for treating acute myeloid leukemia. Blood 122, 3521\u20133532 (2013).","journal-title":"Blood"},{"key":"59969_CR87","volume":"20","author":"RE Kingston","year":"2003","unstructured":"Kingston, R. E., Chen, C. A. & Okayama, H. Calcium phosphate transfection. Curr. Protoc. Cell Biol. 20, 20 (2003).","journal-title":"Curr. Protoc. Cell Biol."},{"key":"59969_CR88","doi-asserted-by":"crossref","unstructured":"Muller, I. et al. MPP8 is essential for sustaining self-renewal of ground-state pluripotent stem cells. Nat. Commun. 12, 3034 (2021).","DOI":"10.1038\/s41467-021-23308-4"},{"key":"59969_CR89","doi-asserted-by":"crossref","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","DOI":"10.1186\/s13059-014-0550-8"},{"key":"59969_CR90","doi-asserted-by":"publisher","first-page":"100575","DOI":"10.1016\/j.xpro.2021.100575","volume":"2","author":"H Damhofer","year":"2021","unstructured":"Damhofer, H., Radzisheuskaya, A. & Helin, K. Generation of locus-specific degradable tag knock-ins in mouse and human cell lines. STAR Protoc. 2, 100575 (2021).","journal-title":"STAR Protoc."},{"key":"59969_CR91","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1182\/blood-2013-08-522094","volume":"123","author":"P Sroczynska","year":"2014","unstructured":"Sroczynska, P. et al. shRNA screening identifies JMJD1C as being required for leukemia maintenance. Blood 123, 1870\u20131882 (2014).","journal-title":"Blood"},{"key":"59969_CR92","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nature13035","volume":"509","author":"RAJ Signer","year":"2014","unstructured":"Signer, R. A. J., Magee, J. A., Salic, A. & Morrison, S. J. Haematopoietic stem cells require a highly regulated protein synthesis rate. Nature 509, 49\u201354 (2014).","journal-title":"Nature"},{"key":"59969_CR93","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/s41596-018-0100-z","volume":"14","author":"LH San Jose","year":"2019","unstructured":"San Jose, L. H. & Signer, R.A.J. Cell-type-specific quantification of protein synthesis in vivo. Nat. Protoc. 14, 441\u2013460 (2019).","journal-title":"Nat. Protoc."},{"key":"59969_CR94","doi-asserted-by":"publisher","first-page":"10350","DOI":"10.1021\/acs.analchem.8b02172","volume":"90","author":"SC Shen","year":"2018","unstructured":"Shen, S. C. et al. Surfactant cocktail-aided extraction\/precipitation\/on-pellet digestion strategy enables efficient and reproducible sample preparation for large-scale quantitative proteomics. Anal. Chem. 90, 10350\u201310359 (2018).","journal-title":"Anal. Chem."},{"key":"59969_CR95","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1074\/mcp.M110.001537","volume":"9","author":"T Geiger","year":"2010","unstructured":"Geiger, T., Cox, J. & Mann, M. Proteomics on an orbitrap benchtop mass spectrometer using all-ion fragmentation. Mol. Cell Proteom. 9, 2252\u20132261 (2010).","journal-title":"Mol. Cell Proteom."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59969-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59969-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59969-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T14:03:15Z","timestamp":1748354595000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59969-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,27]]},"references-count":95,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["59969"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-59969-8","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,27]]},"assertion":[{"value":"13 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"K.H. and K.A. are co-founders of Dania Therapeutics. K.H. is a scientific advisor for Hannibal Innovation and was recently a scientific advisor for Inthera Bioscience AG and for MetaboMed Inc. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4920"}}